Claire Vandevelde

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

Zara Izadi, Erica J. Brenner, Satveer K. Mahil et al. · JAMA Network Open · 2021 · 116 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study

Md Yuzaiful Md Yusof, Jack Arnold, Benazir Saleem et al. · The Lancet Rheumatology · 2023 · 53 citations · Full text

Life Sciences, Immunology, Infectious Diseases +9

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

Sebastian E. Sattui, Richard Conway, Michael Putman et al. · The Lancet Rheumatology · 2021 · 51 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study

Zara Izadi, Milena Gianfrancesco, Gabriela Schmajuk et al. · The Lancet Rheumatology · 2022 · 19 citations · Full text

Public Health, Health Sciences, Infectious Diseases +11

Comparing the Visual Analog Scale and the Numerical Rating Scale in Patient-reported Outcomes in Psoriatic Arthritis

Weiyu Ye, Simon Hackett, Claire Vandevelde et al. · The Journal of Rheumatology · 2020 · 14 citations

Medicine, Dermatology, Health Assessment +16